300-Patient registry tracks nellix® aneurysm sealer in Real-World use
NCT ID NCT02018744
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed registry followed 300 patients with abdominal aortic aneurysm who were treated with the Nellix® Endovascular Sealing System across 30 international centers. The goal was to see how well the device performs in everyday medical practice, measuring safety and effectiveness over up to five years. Researchers tracked complications like aneurysm rupture, device migration, and the need for additional procedures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Nellix® Endovascular Sealing System (a device used to seal abdominal aortic aneurysms from inside the blood vessel)
What this could lead to
If the results confirm the device works well in everyday practice, it could support its continued use for treating abdominal aortic aneurysms.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove the device is better than other treatments. Results may vary across centers and patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABDOMINAL AORTIC ANEURYSM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Academisch Medisch Centrum Amsterdam, Department of Surgery
Amsterdam, 1105AZ, Netherlands
-
Addenbrooke's Hospital, Dept of Vascular Surgery
Cambridge, CB20QQ, United Kingdom
-
Alfried Krupp Krankenhaus Ruttenscheid, Vascular Centre
Essen, 45131, Germany
-
Auckland City Hospital Interventional Radiology
Auckland, 1023, New Zealand
-
Erasmus Medical Centre, Dept of Vascular Surgery
Rotterdam, 3015 CE, Netherlands
-
Hopital Kirchberg, Dept of Cardio-Vascular
Luxembourg-Kirchberg, L-2540, Luxembourg
-
Hospital Hamar
Hamar, 2326, Norway
-
Karolinska University Hospital
Stockholm, SE-171, Sweden
-
Klinikum Augsburg Klinik für Gefäßchirurgie
Augsburg, 86156, Germany
-
Klinikum Stuttgart Katharinenen Hospital
Stuttgart, 70174, Germany
-
Klinikum Sud Nuernberg, Dept of Vascular Surgery
Nuremberg, 90471, Germany
-
Orebro University Hospital, Department of General Surgery
Örebro, Sweden
-
Pauls Stadins Clinical University Hospital Riga
Riga, LV-1002, Latvia
-
Rijnstate Ziekenhuis, Vasculaire Centrum
Arnhem, 6800 TA, Netherlands
-
St Antonius Ziekenhuis, Dept of Vascular Surgery
Nieuwegein, 3435 CM, Netherlands
-
St Elisabeth Ziekenhuis, Dept of Vascular Surgery
Tilburg, 5022 GC, Netherlands
-
St. George's Vascular Institute
London, SW170QT, United Kingdom
-
Universitätsklinikum Düsseldorf Klinik für Gefäß- und Endovaskularchirurgie
Düsseldorf, 40225, Germany
-
Universitätsklinikum Heidelberg Klinik für Gefäßchirurgie Im Neuenheimer Feld
Heidelberg, 69120, Germany